Shots:

• Ultromics has received the US FDA clearance for EchoGo Heart Failure, an AI solution for echocardiography software to detect HFpEF from a single echocardiogram image. The device was being developed in partnership with the Mayo Clinic
• The collaboration focused to develop more precise strategies & targeted therapies to improve survival while minimizing exposure to invasive techniques. The technology improves the accuracy of HFpEF detection and allows more patients to receive treatment, reducing the significant burden on patients & healthcare systems
• The new therapy drugs are now available to patients, incl. SGLT2is that demonstrated to lower hospitalizations & fatal AEs

Ref: PRNewswire | Image: Ultromics